CORC

在结果中检索

CORC

浏览/检索结果: 共9条，第1-9条 帮助

已选(0)清除 条数/页：   排序方式：
Clinical efficacy and safety of mecapegfilgrastim in small cell lung cancer as primary prophylaxis of neutropenia post chemotherapy: a retrospective analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2021, 卷号: 10
作者:  Gu, Xiaodong;  Zhang, Yiping
收藏  |  浏览/下载：39/0  |  提交时间：2021/11/01
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2
作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/04
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2
作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua
收藏  |  浏览/下载：55/0  |  提交时间：2019/12/05
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文
Breast Cancer Research and Treatment, 2018, 卷号: 168, 期号: 2, 页码: 389-399
作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/27
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia 期刊论文
2017, 卷号: 29, 期号: 5, 页码: 402-410
作者:  Qin, Yan;  Han, Xiaohong;  Wang, Lin;  Du, Ping;  Yao, Jiarui
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) 期刊论文
CLINICAL LUNG CANCER, 2016, 卷号: 17, 期号: 2, 页码: 119-127
作者:  Zhou, CC;  Huang, YC;  Wang, DL;  An, CS;  Zhou, FX
收藏  |  浏览/下载：8/0  |  提交时间：2017/01/09
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) 期刊论文
CLINICAL LUNG CANCER, 2016, 卷号: 17, 期号: 2
作者:  Zhou, Caicun;  Huang, Yunchao;  Wang, Donglin;  An, Changshan;  Zhou, Fuxiang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) 期刊论文
CLINICAL LUNG CANCER, 2016, 卷号: 17, 期号: [db:dc_citation_issue], 页码: 119-127
作者:  Zhou, Caicun;  Huang, Yunchao;  Wang, Donglin;  An, Changshan;  Zhou, Fuxiang
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/02
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) 期刊论文
CLINICAL LUNG CANCER, 2016, 卷号: 17, 期号: 2
作者:  Zhou, Caicun;  Huang, Yunchao;  Wang, Donglin;  An, Changshan;  Zhou, Fuxiang
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace